covid-19

---

View Covid research bulletins from the Library

NIHR Portfolio Studies - open to recruitment:

​​

---

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infection [COVID-19]
Principal Investigator: Prof. Anil Hormis
Sponsor: University of Oxford
This study will provide rapid, coordinated clinical investigation of patients with confirmed COVID-19 infection. It will look at how the virus reproduces and is excreted by the body, how the body responds to infection and treatment over time and how the immune system responds. 

---

RECOVERY Trial: Randomised Evaluation of COVID-19 Therapy
​Principal Investigator: Prof. Anil Hormis
Sponsor: University of Oxford
This international clinical trial aims to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19.​​

REMAP-CAP: Randomised, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia
Principal Investigator: Prof. Anil Hormis
Sponsor: University Medical Centre Utrecht / Intensive Care National Audit & Research Centre (ICNARC)
The broad objective of this REMAP is, over time, to determine and continuously update the optimal set of treatments for community-acquired pneumonia. This study will use a study design known as a REMAP, a Randomised, Embedded, Multifactorial, Adaptive Platform trial.
​​